Objective: The aim of this study was to examine the vasoactive effects of rabbit isolated mononuclear leukocytes, and to identify the mediators responsible for those vasoactive effects. Methods: Mononuclear leukocytes (MNLs) were isolated from New Zealand White 7 rabbit whole blood, suspended at 5310 cells / ml and incubated for 30 min at 378C. This cell suspension, or the cell-free supernatant from this suspension, were then examined for vasoactive effects in rabbit isolated thoracic aorta. Results: Both the MNL suspension and the cell-free supernatant from this suspension caused endothelium-independent contraction of aortic rings, both from resting tension and when pre-contracted. The MNL suspension caused a significantly greater contraction than the MNL supernatant under all conditions. The contractions to the MNL product were significantly inhibited by the 5-HT receptor antagonist ketanserin (0.1 mM), but not by the 2 a -adrenoceptor antagonist prazosin (10 mM). High-performance liquid chromatography (HPLC) analysis showed that the MNL 1 supernatant contained serotonin (5-hydroxytryptamine, 5-HT) at an average concentration of 5 mM. Conclusions: We conclude that MNLs cause contraction of rabbit isolated aortic rings by the release of 5-HT.
There have been reports of vasoactive responses to
Introduction
MNLs, however, none of the studies identified the active factor. One study indicated that activated human MNLs Mononuclear leukocytes (MNLs) accumulate at sites of caused increased vascular resistance in cynomolgus moninflammation and are commonly found in atherosclerotic key femoral artery, by releasing a stable factor, which was lesions. They infiltrate the subendothelial space and are ,1000 Da in size, but was not further characterized [8] . proposed to contribute to vascular lesion development by
Other studies indicate that MNLs can increase the potency releasing cytokines [1] , which promote smooth muscle cell of endothelin-1 [9] , inhibit endothelium-dependent relaxaproliferation [2] . Cytokines also promote further recruittion [10] and that migration of MNLs into vascular lesions ment of leukocytes [3] , which may lead to endothelial cell may increase the sensitivity of the rabbit carotid artery to damage [2] and the release of vasoactive substances, the contractile effects of serotonin (5-HT) [11] . Monocyte / including arachidonic acid metabolites such as prostamacrophages, but not lymphocytes, are also implicated as a glandin E (PGE ) and thromboxane A (TXA ) [4] source of vasoactive mediators in cerebral ischaemia and oxygen free radical species [5] . Furthermore, human stroke [12] but, as noted above, the identity of the mononuclear cells have recently been shown to contain vasoconstrictor(s) remains unknown. both angiotensin I and angiotensin II [6] and human
The aims of this study were to characterize the vasoacmacrophages are reported to synthesize and secrete tive effects of MNLs or products released from MNLs on endothelin-1 and endothelin-3 [7] . Thus, MNL-derived rabbit isolated aorta, and to identify the mediators inproducts have the potential to cause significant effects on volved. This report provides evidence for the release of vascular tone, particularly in areas of inflammation.
5-HT from MNLs. This finding may be of particular significance in atherosclerosis, as MNLs are known to 2.3. Composition and viability of MNL suspensions accumulate, and are probably activated, in atherosclerotic vascular lesions [13] .
A sample (50 ml) of each of the isolated mononuclear or polymorphonuclear cells was stained with gentian violet and trypan blue to assess cell number and viability. Cell viability was always .95%. In addition, the number of 2. Methods platelets was also counted in some of the preparations. In some experiments, a further sample of the MNL suspenAll experimental procedures were carried out within the sion was applied to a microscope slide using a cytospin guidelines of the National Health and Medical Research centrifuge. These slides were fixed with ethanol, then Council of Australia, and were approved by the University stained with Giemsa's stain and the MNL subtypes were of Melbourne Animal Experimentation Ethics Committee.
counted.
Preparation of platelet supernatant 2.1. General procedures
Platelets isolated from the plasma were washed twice in New Zealand White rabbits of either sex were anaesthetTyrode's solution (5 min, 10003g) and then resuspended ised by intravenous administration of Saffan® (alphax -7 at 5310 platelets / ml in Tyrode's solution, the concenalone, 9 mg / ml, and alphadolone acetate, 3 mg / ml, diluted tration found to be contaminating the MNL suspension. 1:2 with sterile normal saline). The carotid artery was
The platelet suspension was incubated at 378C for 30 min. isolated and cannulated and blood was collected into
The supernatant was then obtained by centrifuging the syringes containing sodium citrate (final concentration, suspension again (5 min, 10003g) and discarding the 3.8%, w / v). When all of the blood was removed (usually platelets. 100-120 ml) the thorax was quickly opened and the thoracic aorta was removed and stored in Krebs-bicarbon-2. cut into rings that were approximately 4 mm in length. The rings were mounted in siliconised, 10 ml organ baths on a 2.2. Isolation of rabbit mononuclear leukocytes fixed hook and a second hook, which was connected to a force transducer (model [ FT03, Grass Medical InstruMNLs were isolated from whole blood under sterile ments, USA) bathed in Krebs-bicarbonate solution mainconditions using cell-culture grade, endotoxin-tested retained at 378C with a water jacket and continuously agents and solutions. Plasma was removed by centrifugabubbled with a mixture of 95% O and 5% CO . The rings 2 2 tion (15 min, 7503g) and then centrifuged again to obtain were allowed to equilibrate for at least 40 min, during platelet-poor plasma (10 min, 10003g). Most of the which time the passive tension was adjusted to 2 g. erythrocytes were removed from the remaining blood by Changes in tension were recorded on a chart recorder sedimentation with Dextran T500 (5 ml; 6%, w / v). The (model [ R-02, Rikadenki Kogyo, Japan), which was leukocyte-rich top layer was removed and centrifuged (10 calibrated immediately prior to each experiment. In some min, 7503g). The resulting pellet was resuspended in a experiments, the endothelium was deliberately removed by solution of platelet-poor plasma (2 ml) and normal saline rubbing the luminal surface gently with a wooden stick, to (8 ml), then underlayered with Lymphoprep® (3 ml) and examine the role of the endothelium in the responses. centrifuged (20 min, 8503g) and 0.25% (w / v) bovine serum albumin (BSA); pH 7.4). were first treated with 0.4 M perchloric acid, to preserve The cells were resuspended at a final concentration of the monoamines and precipitate any proteins that were 7 5310 cells / ml and incubated for 30 min at 378C. The cell present. Samples were then centrifuged to remove the suspensions were then used in isolated aorta experiments, protein and then were diluted with water prior to analysis. or the incubation medium was obtained as the supernatant
The HPLC analysis equipment consisted of a reversedfrom the cell suspension following centrifugation (5 min, phase micro-guard cartridge (BioRad) followed by a 10003g). This supernatant was used immediately, or clinical HPLC reversed-phase column (BioRad). Noradstored for up to four months at 2208C.
renaline, adrenaline and serotonin in the eluent from the column were detected by an electrochemical cell (BAS 2.8. Drugs and reagents used LC4B amperometric detector) set at 650 mV. The mobile phase employed consisted of 70 mM KH PO , 8 mM
For the collection and preparation of isolated leukocytes, 2 4 sodium octane sulphonate, 0.5 mM Na EDTA, with the pH Saffan® was obtained from Pitman Moore (Australia) and 2 adjusted to 3.0 with orthophosphoric acid. Methanol (10%, diluted two-fold in sterile 0.9% NaCl prior to use. Dextran v / v) was added to the mobile phase for the detection of T500 was from Pharmacia (Sweden) and prepared as a 6% serotonin. Using this method, the detection thresholds for solution in sterile 0.9% NaCl. Lymphoprep® was obtained these analyses were determined to be 0.02 mM for from Nycomed (Norway). Tyrode's salts, 1 M HEPES noradrenaline, 0.04 mM for adrenaline and 0.03 mM for buffer and 0.25% BSA were all endotoxin-tested reagents 5-HT.
purchased from Sigma (St. Louis, MO, USA). Crystal violet and trypan blue were also from Sigma, and the Diff-Quick® kit (modified Wright stain) was from Lab-2.7. Experimental protocols Aids (Australia). L-Phenylephrine hydrochloride (PE), indomethacin, 5-hydroxytryptamine creatinine sulphate (5-
Following a 45-min equilibration period, all aortic rings HT), angiotensin II acetate salt and [Sar , Ala ]-angiotenwere assessed for endothelial integrity by recording the sin II acetate salt (saralasin) were all obtained from Sigma. endothelium-dependent relaxation elicited by acetylcholine O-Acetylcholine perchlorate was obtained from BDH (ACh, 3 mM), after sub-maximal contraction with Chemicals (UK), ketanserin tartrate was from Jannsen phenylephrine (PE, 0.03-0.1 mM). The pre-contractions (Belgium), benzenemethanol,a-pentyl-3-(2-were always matched between aortic rings and the mean quinolinylmethoxy)-C H NO (REV 5901) was from 22 25 2 relaxation was 7861% of the PE-induced pre-contraction, Cayman Chemicals (USA) and prazosin hydrochloride was and it was accepted that the endothelium was functionally obtained from Pfizer (USA). PE, ACh, bosentan, 5-HT, intact if this relaxation was greater than 50% of the ketanserin, prazosin and saralasin were all dissolved in pre-contraction. Any unrubbed rings with less than 50%
water, indomethacin was dissolved in Na CO (0.1 M), 50 curve. Only one dose-response curve to the MNL supernapresence of an antagonist, Student's t-test was used. tant or suspension was constructed in any single aortic Statistical significance was accepted when P,0.05. ring. The concentrations of prazosin (10 mM), indomethacin (3 mM) and REV-5901 (0.1 mM) used in these experiments are equal to or greater than concentrations 3. Results have been shown to effectively inhibit a -adrenoceptor-1 mediated contraction [14] , prostaglandin synthesis [15] or 3.1. Composition of the MNL suspensions leukotriene receptor-mediated contraction [16] , respectively. The effectiveness of ketanserin (0.1 mM), bosentan (10 The MNL suspensions contained (in %): lymphocytes mM) and saralasin (0.1 mM) was confirmed by their ability 82.662.8, monocytes 13.362.1, neutrophils 4.361.8 and to inhibit contractile responses to 5-HT, endothelin-1 and basophils 0.560.1 (n514). Platelets were present in the angiotensin II, respectively. In these experiments, the same MNL suspensions at an average concentration of 7 MNL sample was used to obtain results with and without 5.861.7310 / ml (n511). the inhibitor. The response to platelet-released products (platelet supernatant) was also examined in aorta from 3.2. Effect of MNL suspension on aorta resting tension, with intact endothelium, using the same cumulative dose-response method as described above.
Original traces of the responses to MNL suspension in rabbit aortic rings from resting tension, or submaximally pre-contracted, with intact endothelium are reproduced in Fig. 1 . MNL suspension caused a dose-dependent contraction of rings from resting tension, and a dose-dependent further contraction of rings that had been pre-contracted with PE. The group data is shown in Fig. 2 . Contractions to the MNL suspension were not dependent upon a functioning endothelium, and the threshold of the response to MNL suspension in pre-contracted rings is lower than the threshold in the rings from resting tension (Fig. 2) .
Effect of MNL supernatant on aorta
Original traces of the response to MNL supernatant in aorta from resting tension, or submaximally pre-contracted, with intact endothelium are reproduced in Fig. 3 . MNL supernatant caused a dose-dependent contraction of rings from resting tension, and a dose-dependent further contraction of aorta that had been pre-contracted with PE. The group data is shown in Fig. 4 . The maximum response to MNL supernatant from resting tension was not different to the response in pre-contracted aorta, nor was the level of the response influenced by the presence or absence of the endothelium (Fig. 4) . The threshold of the response to MNL supernatant in pre-contracted rings is lower than the threshold in the rings from resting tension (Fig. 4) . The contraction response to MNL suspension was greater than the response to MNL supernatant in both aorta from resting tension and when pre-contracted (ANOVA, P, 0.05).
Effect of inhibitors on the response to MNL-derived products
3.4.1. Indomethacin MNL supernatant (derived from 5310 MNLs / ml) caused a dose-dependent contraction in aorta from resting tension (A) and in aorta that had been submaximally pre-contracted with phenylephrine (0.03 mM) (B). Doses added are in ml. by the presence of saralasin [maximum contraction (g): control 5.261.5; saralasin-treated 6.061.5, n55).
Bosentan
The contraction response to MNL supernatant was unaffected by the endothelin receptor antagonist bosentan 3.4.5. Ketanserin The contractile response to MNL supernatant was contractile response to MNL suspension was not affected unaffected by the a -adrenoceptor antagonist prazosin (10 wash in an attempt to reduce the platelet contamination of the MNL isolates. The extra wash resulted in approximately a 30% reduction in the number of platelets in the 6 suspension [platelet count (310 / ml): normal wash 60612; extra wash 3967, n54], but had no effect on the contractile response to the MNL supernatant (Fig. 7) . 7 Platelet supernatant obtained from a suspension of 5310 platelets / ml (equivalent to the average platelet contamination of the MNL preparations) had no significant contractile effect (Fig. 7) . 
HPLC measurement of amines in the MNL supernatant
Neither the vehicle nor samples of the MNL supernatant contained any detectable adrenaline or noradrenaline. However, the MNL supernatant contained 5.061.0 mM serotonin (n54). There was no detectable 5-HT in the vehicle. In some experiments, the MNL were given an extra to platelet supernatant).
Discussion
carotid artery to the contractile actions of 5-HT [11] . The results of the present study suggest that this may be due to These results show that mononuclear cells release a the additive effects of the 5-HT released by the mononufactor that causes contraction of rabbit thoracic aorta.
clear cells to the exogenously applied 5-HT used to MNL-derived products caused a dose-dependent contracconstruct the dose-response curves. tion of rabbit aorta from resting tension, and a further Other reports of vasoactive effects of monocytes include contraction of pre-contracted aorta. The contractile rea study which shows that endothelin-1-induced vasoconsponses were unaffected by the removal of the endostriction is increased in the presence of monocytes and thelium. Experiments carried out in the presence of a range suggests that this effect is mediated by the stimulation of of inhibitors indicate that the factor is not endothelin, an in monocyte endothelin receptors. Although the mechanism situ product of cyclo-oxygenase, a lipoxygenase product or of this potentiation was not determined [9] , the effect is angiotensin II. However, the response to MNL products consistent with the ability of 5-HT to enhance contractile was significantly inhibited by the 5-HT receptor antagoresponses to endothelin [23] . Another group reported that a 2 nist ketanserin, but not by the a -adrenoceptor antagonist mediator derived from human MNLs, and also from other 1 prazosin. The lack of effect of prazosin is important, as human cell types, causes inhibition of endothelium-depenketanserin is known to have some a-adrenoceptor antagodent relaxation in rat aortic rings, together with small nist properties [17] , so this result indicates that the factor endothelium-dependent contraction of pre-contracted rat responsible for the contraction was 5-HT and not another aorta [10] . Clearly, this factor was not 5-HT and suggests amine acting on a-adrenoceptors. Further to this, supernathat there may be differences in mediator release across tant from the MNL suspension was found to contain an species. The literature cited here supports the hypothesis average of 5 mM 5-HT when analysed by HPLC, whereas that leukocytes produce vasoactive factors, and we propose there was no detectable adrenaline or noradrenaline. All of that 5-HT may be involved in some of the previous reports the data presented indicate that the contractile factor of MNL-derived constriction. released by MNLs is 5-HT.
MNL products caused contraction of aorta from both MNLs have previously been shown to have vasoactive resting tension and when precontracted. It is notable thaẗ effects. Studies by Mugge et al. [8, 18] demonstrated that the threshold dose of the MNL response in the preactivated human mononuclear cells caused vasoconstriccontracted rings is lower than in rings from resting tension. tion of the cynomolgus monkey femoral artery in vitro.
This lower threshold may be explained by 5-HT-mediated Interestingly, the results of these studies showed that potentiation of the phenylephrine-induced contraction and human MNLs released a stable factor that caused an is consistent with observations that sub-contractile conendothelium-independent contraction. The responsible faccentrations of 5-HT enhance responses to other vasocontor was neither a metabolite of the cyclo-oxygenase or strictors [24] . Both MNL suspension and supernatant lipoxygenase pathways, nor a free radical, but a heat-stable caused contractions that were independent of the endomolecule ,1000 kDa in size. It was suggested that the thelium, as there was no statistically significant difference factor may be angiotensin II, but no data was provided to in the responses in rings with endothelium intact and support that hypothesis [4] . Since the observations of endothelium that was denuded. Typically, 5-HT causes ä Mugge et al. [8] are consistent with our report, we suggest greater contraction in aortic rings without endothelium, that the factor responsible for the contraction in their study where the modulatory effect of the endothelium is removed may also have been 5-HT. [21] , and there was a tendency for this to occur with the Further studies in cynomolgus monkeys showed that in MNL suspension, but not the supernatant. vivo activation of leukocytes with the tri-peptide N-
The contractions caused by the MNL suspension were formyl-Met-Leu-Phe (f-MLP) caused a marked constricsignificantly greater than those caused by the supernatant tion of hindlimb large arteries [19] and a decrease in ocular alone, which may be due to an interaction between the and cerebral blood flow [20] in atherosclerotic, but not aorta and the MNLs. This interaction may result in control, animals. Unfortunately, these in vivo studies are activation of the leukocytes and a greater release of their limited in that there can be no differentiation between the stored substances, as it is reported that MNLs activated effects of activating polymorphonuclear leukocytes or with interferon g [25] or cisplatin [26] release larger MNLs, however, it is possible that 5-HT released from amounts of serotonin. The maximum contractions caused MNLs may have contributed to the constriction observed by the MNL products were smaller when the aortic rings in those studies. It is also important to note that 5-HTwere precontracted, probably because the rings were induced constriction is more likely to occur in atherosalready approaching the maximum attainable contraction. clerotic vessels [21, 22] and that MNLs accumulate at sites Although the MNLs were not specifically stimulated by of inflammation, and are probably activated in atherosany agent, the activation status of cells was not assessed, clerotic plaques [13] . There has also been a report sugso it is possible that the MNLs were activated by the gesting that early migration of mononuclear cells into isolation and incubation procedures. The MNL suspension vascular lesions increases the sensitivity of the rabbit used in this study contained mostly lymphocytes (83%) and some monocytes (13%). It is not known which of and that MNL-derived 5-HT causes significant contraction these cell types is responsible for the 5-HT release, or of rabbit aortic rings. MNLs are known to play a role in indeed if both cell types are involved.
vasoconstriction, particularly in atherosclerosis, and MNLThe suspension was also contaminated with basophils derived 5-HT may be the mediator responsible for the and platelets. Platelet contamination was minimized as far vasoactive effects observed in several studies. 5-HT is not as possible in the preparation procedure by removing the only specifically taken up by MNLs, but there is evidence platelet-rich plasma prior to dextran sedimentation, and by that these cells may also have the capacity for 5-HT further washing after separating the MNLs from the synthesis and, in addition, 5-HT has a role in MNL polymorphonuclear cells. However, platelet contamination immunomodulation. The data presented suggests that 7 was still evident (average of 5.8310 platelets / ml in each MNL-derived 5-HT may be an important modulator of MNL suspension). To control for this, a suspension of vessel tone. 7 platelets was prepared at a similar concentration (5310 platelets / ml), incubated and the supernatant collected as for the MNL supernatant. This platelet supernatant had no Acknowledgements significant contractile effect, indicating that the platelet contamination had little role in the responses shown. In 1 We wish to thank Dr. James Ziogas for supplying [Sar , addition, a thorough study of the contents of platelets, 8 7 Ala ]-angiotensin II, and the Roche Co. for their generous undertaken by Meyers et al. [27] , showed that 5310 gift of bosentan. We also thank Ms. Melanie O'Farrell and rabbit platelets contain only 1.7 nmol 5-HT, more than Dr. Philip Marley for carrying out the HPLC analyses. 2000-fold less than was measured in the MNL supernatant, Thanks also to Ms. Vitina Sozzi and Ms. Sarah Emselle for supporting our result. It is important to note that platelets their expert technical assistance. This work was supported and leukocytes are known to interact and modulate each by the Smoking and Health Research Foundation of other's function. In particular, leukocytes are reported to Australia. inhibit platelet-derived vasorelaxation [4, 28] and, although it is unlikely in the present study given the relatively low level of platelets, a synergistic interaction between the MNLs and the platelets, which may enhance vasoconstric
